USA Financial Formulas Takes Stake in Merck & Co., Inc.
USA Financial Formulas has purchased a new stake in Merck & Co., Inc. ($MRK) during the first quarter, according to its SEC filing.
The fund acquired 7,410 shares of the company's stock, valued at approximately $891,000.
This is not an isolated case; other hedge funds have also bought and sold MRK shares in recent quarters.
RBC Capital Markets downgraded Merck to Sector Perform with a target price of $150, citing execution risks and the 2028 Keytruda loss of exclusivity.